The upcoming 2-day event will feature more than 25 experts speaking on skin care, scalp care, probiotics, regulations, and much more.

The Skin Microbiome Congress will take place May 30 and 31 in Boston, Massachusetts. And, the just-released agenda, from event host Kisaco Research, invites prospective attendees to “join 100+ industry leaders to explore the different pathways to market and how to translate therapeutic research into commercially viable cosmetic products.”​

The Skin Microbiome Congress is structured to include 15 + hours of networking opportunities and a digital platform where attendees can message and set up meetings with anyone at the event.

And the programming has been developed to help attendees “Recognize the major consumer trends reshaping the beauty and personal care landscape, and identify the actions needed to differentiate your product lines and gain market share….​ [to] navigate the challenges and opportunities in designing, formulating, manufacturing and packaging health-enhancing skin care products that contain live bacteria, bacterial extracts, or post-biotic ingredients to enhance skin microbe activity,” ​and everything in between, according to event marking materials. ​

Speaking and educating ​

Among the speakers on the first day of the congress are Dr. Roshini Raj, co-founder of TULA and Julia Straus, CEO of the brand. Early last year L Catterton invested in the probiotic skin care brand, as Cosmetics Design reported​. One reason cited for the investment was TULA’s impressive consumer following on Beauty iQ, the all beauty channel of QVC. The brand knows how to connect with consumers; and at the congress Raj and Straus will be discussing consumer demand and why beauty shoppers are “going crazy for beneficial bacteria.”​

Also on day one, Jason Harcup, global vice president of personal care research and global vice president of the prestige division R&D at Unilever, will speak about commercializing microbiome-based personal care products.

Then on day two, Cécile Clavaud, project leader of the skin microbiome unit of L’Oréal’s research and innovation division, will speak about the scalp microbiome. And that same day Kimberly Capone, research fellow and lead microbiologist for skin microbiome research at J&J Consumer Companies will present clinical trial data on atopic dermatitis.